Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction

Highlights

  • In a right heart catheterization sample, prevalence of PH was similar among women and men.

  • Precapillary PH was more common in women, and postcapillary PH more common in men.

  • Women with PH have better hemodynamic indices of RV function and a lower risk of subsequent HF hospitalization.

  • Understanding sex differences across PH subtypes is paramount to sex-based risk stratification.

Prior studies have established the impact of sex differences on pulmonary arterial hypertension (PAH). However, it remains unclear whether these sex differences extend to other hemodynamic subtypes of pulmonary hypertension (PH). We examined sex differences in PH and hemodynamic PH subtypes in a hospital-based cohort of individuals who underwent right heart catheterization (RHC) between 2005 and 2016. We utilized multivariable linear regression to assess the association of sex with hemodynamic indices of right ventricle (RV) function (PA pulsatility index [PAPi], RV stroke work index [RVSWI], and right atrial: pulmonary capillary wedge pressure ratio [RA:PCWP]). We then used Cox regression models to examine the association between sex and clinical outcomes among those with PH. Among 5,208 individuals with PH (mean age 64 years, 39% women), there was no significant sex difference in prevalence of PH. However, when stratified by PH subtype, 31% of women versus 22% of men had precapillary (p <0.001), 39% versus 51% had postcapillary (p <0.001), and 30% versus 27% had mixed PH (p = 0.03). Female sex was associated with better RV function by hemodynamic indices, including higher PAPi and RVSWI (p <0.001 for both). Over 6.3 years of follow-up, female sex was associated with a lower risk of heart failure hospitalization (HR 0.83, 95% CI 0.74 to 0.91, p <0.001). In conclusion, across a broad hospital-based sample, more women had precapillary and more men had postcapillary PH. Compared with men, women with PH had better hemodynamic indices of RV function and a lower risk of heart failure (HF) hospitalization.

Pulmonary hypertension (PH) is a heterogenous disease associated with poor clinical outcomes. While clinically PH is classified by World Health Organization groups based on etiology, grouping by hemodynamic assessment into precapillary PH, postcapillary PH, and mixed pre and postcapillary PH, carries significant prognostic and therapeutic implications, particularly for those with a precapillary component. In addition, one of the strongest predictors of mortality in this patient population is RV dysfunction, a frequent long-term consequence of PH associated with poor prognosis.

Sex differences have long been observed in pulmonary arterial hypertension (PAH), a subset of PH with precapillary hemodynamic characteristics. Specifically, PAH has a higher prevalence in women compared with men, and yet men appear to have worse RV function and survival. The etiology of these differences remains unclear, but some have postulated that sex hormones such as higher levels of estrogen may be responsible for both the increased risk women face in developing PAH as well as their improved RV function and survival compared with men.

Despite the extensive study of sex differences in prevalence and clinical trajectory of PAH, little is known about sex differences across other hemodynamic PH subtypes. In this context, we sought to study sex differences in PH prevalence, associated RV dysfunction, and clinical outcomes across a broad and clinically heterogeneous hospital-based sample of individuals undergoing right heart catheterization (RHC). Based current knowledge of PAH, we hypothesized that (1) women would have a higher prevalence of precapillary PH compared with men, which would not persist across other hemodynamic subtypes, and (2) across all hemodynamic PH subtypes, women would demonstrate better RV function and clinical outcomes compared with men.

Methods

Study sample

Our study examined ambulatory and hospitalized patients who underwent RHC between 2005 and 2016 at Massachusetts General Hospital. If an individual underwent multiple RHC procedures during this period, only the initial RHC was included for analysis. A total of 10,306 cases were included. Cases were excluded if they met the following clinical exclusion criteria: acute myocardial infarction (MI) occurring on the same day as catheterization, cardiac arrest or shock within 24 hours, presence of mechanical ventilation, presence of intra-aortic balloon pump, history of heart or lung transplant, complicated adult congenital heart disease, history of valvular replacement, or those on dialysis (n = 887). Cases were also excluded if there were missing key clinical covariates (n = 484), patient identifier variables (n = 398), or hemodynamic parameters (n = 252), which led to a final study sample of 8,285 cases. This study was approved by the appropriate Institutional Review Board.

Clinical, PH, and RV hemodynamic variables

The following clinical characteristics were extracted from the medical record at the time of RHC: age, sex, body mass index (BMI), smoking status, and presence of comorbidities (diabetes mellitus, hypertension, history of MI, history of heart failure (HF), prior lung disease, and chronic kidney disease). Obstructive sleep apnea (OSA) was ascertained from the electronic medical record utilizing International Classification of Diseases Ninth Revision ( ICD‐9 ) or Tenth Revision ( ICD‐10 ) codes.

Hemodynamic measures were recorded directly from the time of RHC, including resting blood pressure, heart rate, mean right atrial (RA) pressure, pulmonary artery (PA) systolic and diastolic pressure, transpulmonary gradient (TPG), and mean pulmonary capillary wedge pressure (PCWP). Any nonphysiologic parameters were set to missing. The PA pulsatility index (PAPi) was calculated as P A s y s t o l i c − P A d i a s t o l i c p r e s s u r e R A p r e s s u r e . If RA pressure was recorded as zero, the value was set to one to allow for PAPi calculation. If RA pressure was recorded as negative, this was deemed nonphysiologic and set to missing, which affected <1% of measurements. Cardiac output and index measurements were obtained via thermodilution methods whenever possible. If not available, assumed Fick cardiac output and index were used. Both were indexed using the Mosteller formula for body surface area. Right ventricular stroke work index (RVSWI) was calculated as 0.0136 x stroke volume index x (Mean PA pressure-mean RA pressure) , where stroke volume index was calculated by dividing cardiac index by heart rate.

PH was defined as mean PA pressure (mPAP) > 20 mmHg based on the 2022 European Society of Cardiology/European Respiratory Society guidelines. We further categorized PH into three hemodynamic subtypes: precapillary PH (TPG > 12 mm Hg and PCWP ≤ 15 mm Hg), postcapillary PH (TPG ≤ 12 mm Hg and PCWP > 15 mm Hg), and mixed PH (TPG > 12 mm Hg and PCWP > 15 mm Hg). We utilized TPG cutpoints rather than pulmonary vascular resistance (PVR) as not all participants had available cardiac output. For those with cardiac output data, we examined PH hemodynamic subtypes using PVR instead of TPG in secondary analyses.

Clinical outcomes

Primary clinical outcomes included all-cause mortality and HF hospitalization. All‐cause mortality was ascertained using the National Social Security Death Master Index and hospital records, abstracted on 06/10/2020. Due to confidentiality purposes, the precise dates of deaths that occurred between 06/10/2017 and the date of abstraction are protected nationally. Time-to-event analyses were conducted by imputing death dates at the midpoint of the blanking period (12/10/2018).

HF hospitalizations were defined using an ICD-9 or ICD-10 code for HF as the primary discharge diagnosis or a current procedural terminology code for heart transplantation or durable ventricular assist device. The follow‐up period for each participant was defined as time from RHC to death date or date of final encounter in the electronic health record. Patients were censored based on time of last encounter.

Statistical analysis

The distribution of PAPi was winsorized to limit effect of outliers on the analysis, setting the minimum at 0.3 and the maximum at 30 (2 patients had PAPi < 0.3, and 51 patients had PAPi > 30 prior to winsorizing). Baseline characteristics among those with PH were summarized across the total sample by sex. Sex differences in prevalence of PH and PH subtypes were examined using Chi squared tests. We examined cross-sectional associations of sex with hemodynamic indices of RV function among those with PH, including PAPi, RVSWI, and RA:PCWP ratio using multivariable linear regression. Models were adjusted for the following clinical covariates: age, BMI, hypertension, diabetes mellitus, OSA, chronic lung disease, prevalent MI, prevalent HF, chronic kidney disease.

We next constructed multivariable Cox models to examine the association of sex with outcomes, adjusting for covariates as above. In secondary models, we stratified by PH hemodynamic subtype. In exploratory analyses, we evaluated whether sex modified the association of RV function with adverse outcomes among those with PH using multiplicative interaction terms (sex*PAPi, sex*RVSWI, and sex*RA:PCWP ratio). Analyses were conducted using SAS software, Version 9.4 (Cary, NC).

Results

Sex differences in prevalence of PH and hemodynamic subtypes

Among 8,285 individuals who underwent (RHC) between 2005 and 2016, 5,208 (63%) met criteria for PH, as defined by a mPAP >20 mmHg. There was no significant sex difference in the prevalence of overall PH, with 2,032 (62%) women and 3,176 (63%) men meeting PH criteria (p = 0.96, baseline characteristics in Supplemental Table 1 ).

Among individuals with PH, average age was 64 ± 12 years and 39% were women. Men were significantly more likely to have comorbid conditions including previous MI, previous HF, hypertension, diabetes mellitus, hypercholesteremia, and OSA (p <0.001 for all). However, women were more likely to have chronic lung disease (20.2% vs 16.7%, p <0.001). Additional baseline characteristics of individuals with PH are shown in Table 1 .

Table 1

Clinical characteristics of men and women with PH, n = 5,208

Men (n = 3,176) Women (n = 2,032) p-value
Clinical characteristics
Age (y) 64 ± 12 64 ± 12 0.04
Race, n (%) 0.47
Asian 63 (2.0) 48 (2.4)
Black 150 (4.7) 106 (5.2)
Hispanic 93 (2.9) 68 (3.3)
Unknown 195 (6.1) 138 (6.8)
White 2,675 (84.2) 1,672 (82.3)
BMI, kg/m 2 30.0 ± 6.5 30.5 ± 8.4 <0.001
Current smoker, n (%) 210 (6.6) 113 (5.6) 0.03
Previous kidney disease, n (%) 144 (4.5) 57 (2.8) <0.001
Diabetes mellitus, n (%) 922 (29.0) 479 (23.6) <0.001
Hypertension, n (%) 2,045 (64.4) 1,105 (54.4) <0.001
Hypercholesterolemia, n (%) 2,090 (65.8) 1,084 (53.3) <0.001
Chronic lung disease, n (%) 531 (16.7) 410 (20.2) <0.001
OSA, n (%) 588 (18.5) 280 (13.8) <0.001
Previous MI, n (%) 829 (26.1) 250 (12.3) <0.001
Previous HF, n (%) 1,367 (43.0) 690 (34.0) <0.001
Previous valvular disease, n (%) 1,150 (36.2) 734 (36.1) 0.14
NT pro BNP, pg/ml 2,344 [831 to 5,592] 2,085 [747 to 5,217] 0.05
Hemoglobin, g/dl 12.9 ± 2.3 12.2 ± 2.3 <0.001
Hemodynamics
Heart rate, Beats/min 74 ± 16 76 ± 16 <0.001
Systolic blood pressure, mm Hg 122 [106 to 140] 133 [116 to 153] <0.001
Mean arterial pressure, mm Hg 85 [76 to 95] 88 [78 to 98] <0.001
PA Systolic pressure, mm Hg 44 [37 to 55] 45 [37 to 55] 0.30
PA diastolic pressure, mm Hg 19 [15 to 25] 19 [14 to 2] 0.06
Mean RA pressure, mm Hg 9 [6 to 13] 8 [6 to 12] <0.001
Mean PCWP, mm Hg 19 [14 to 24] 17 [13 to 22] <0.001
TPG, mm Hg 10 [7 to 15] 12 [9 to 17] <0.001
PVR, woods units (WU) 2.05 [1.4 to 3.1] 2.5 [1.7 to 3.8] <0.001
PAPi 2.9 [1.9 to 4.4] 3.25 [2.2 to 5.1] <0.001
RVSWI, gm-m/m 2/beat 9.4 [7.1 to 12.6] 10.2 [7.6 to 13.6] <0.001
RA pressure: PCWP ratio 0.5 [0.4 to 0.7] 0.5 [0.4 to 0.7] 0.36
Thermodilution cardiac output, l/min 5.0 [4.2 to 6.2] 4.7 [3.8 to 5.8] <0.001
Thermodilution cardiac index, l/min/ m 2 2.4 [2.0 to 2.9] 2.6 [2.2 to 3.2] <0.001

Table displays mean ± standard deviation and median (interquartile range).

HF = heart failure; MI = myocardial infarction; NT pro-bnp = N-terminal pro-B type natriuretic peptide; OSA = obstructive sleep apnea; PA = pulmonary artery; PCWP = pulmonary capillary wedge pressure; PVR = peripheral vascular resistance; PAPi = pulmonary artery pulsatility index; RA = right arterial; RVSWI = RV stroke work index; TPG = transpulmonary pressure gradient.

We found that hemodynamic PH subtypes significantly differed by sex, with women more likely to have precapillary PH and men more likely to have postcapillary PH ( Figure 1 ). Specifically, 31% of women versus 22% of men had precapillary PH (p <0.001), 39% versus 51% had postcapillary PH (p <0.001), and 30% versus 27% had mixed PH (p = 0.03).

Figure 1

Prevalence of hemodynamic PH subtypes in women (red) and men (blue). Among women with PH, 31% (n = 544) had precapillary PH, 39% had postcapillary PH (n = 685), and 30% had mixed (n = 527). Among men with PH, 22% (n = 605) had precapillary PH, 51% had postcapillary PH (n = 1,402), and 27% had mixed (n = 743). Note that total individuals of PH in our study was 5,208 (vs 4,506 noted here); individuals who did not meet criteria for either precapillary, postcapillary, or mixed PH were excluded in assessing prevalence of subtypes. (PH = pulmonary hypertension).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 8, 2026 | Posted by in CARDIOLOGY | Comments Off on Sex Differences in Pulmonary Hypertension and Associated Right Ventricular Dysfunction

Full access? Get Clinical Tree

Get Clinical Tree app for offline access